Drug Type Cell therapy |
Synonyms SRT-001 |
Target |
Mechanism CD47 modulators(Cluster of differentiation 47 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thalassemia | Preclinical | US | 13 Dec 2023 | |
Anemia, Sickle Cell | Preclinical | US | - |